A colossal US$4.6 billion (about NZ$7.7 billion) class action against global wealth‑tech group FNZ has opened in the New Zealand High Court, immediately triggering a fierce procedural fight over whether the dispute belongs in Wellington’s courtroom or behind closed doors in offshore arbitration rooms in London.
Billed as one of the largest corporate shareholder actions in Asia‑Pacific, the class action lawsuit has been brought on behalf of hundreds of current and former employee‑shareholders against FNZ Group and 17 of its current and former directors.
The major class action claim is advanced through a Cayman‑based vehicle acting for FNZ’s Class B employee shareholders, a structure designed to shield individual staff from potential retaliation and to streamline what would otherwise be a sprawling multi‑jurisdictional proceeding.
The legal teams and the dispute
The employee‑shareholders are represented in New Zealand by litigation firm Meredith Connell, which has been coordinating a transnational group of staff investors across the UK, Australia, New Zealand and Asia.
The claimants allege that FNZ and its directors orchestrated a sophisticated dilution play that stripped employee equity of most of its value while delivering a multi‑billion‑dollar upside to institutional backers.
FNZ is represented by Russell McVeagh and Sarah Armstrong KC.
On the defence side, FNZ founder Adrian Durham (left) is represented by Jason Goodall KC and a roster of heavyweight directors have been named, including board representatives connected to the Canada Pension Plan Investment Board (CPPIB), Caisse de dépôt et placement du Québec (CDPQ), Singapore’s Temasek, Al Gore’s Generation Investment Management, and private equity firm Motive Partners.
The claim also targets individual directors who allegedly sat on both sides of the transactions – as FNZ fiduciaries and as representatives of the very institutional investors said to have benefited from the contested capital raisings.
At the core of the case are allegations of minority shareholder oppression and breaches of directors’ duties under New Zealand’s Companies Act 1993, including the oppression remedy in s 174 and the core duties to act in good faith and for proper purposes in ss 131–133.
The employee‑shareholders say three capital raises completed in 2024 and 2025 – together injecting about US$1.5 billion into FNZ – were completed on uncommercial terms, involving deeply preferential share structures and “penny warrants” issued to institutional investors that all but obliterated the value of ordinary employee shares.
According to the statement of claim, those transactions effectively transferred an estimated US$4.6 billion of equity from employees to institutional investors by guaranteeing those investors multiples on their money and priority returns in any exit, while leaving staff vulnerable to being wiped out if FNZ’s valuation fell below an US$8.3 billion threshold in a sale or IPO.
The action alleges 16 instances of oppressive and unfairly prejudicial conduct, misuse of powers and failures to properly manage conflicts of interest at board level.
For those wanting to track the statutory framework, the key provisions are found in New Zealand’s Companies Act 1993, particularly the oppression remedy in s 174 and the directors’ duties in ss 131–137, as published on the official New Zealand Legislation website.
The jurisdiction and arbitration clash
FNZ was founded in Wellington in 2003 and remains a New Zealand‑incorporated company, even as it has grown into a global wealth‑tech platform administering more than US$2 trillion in pension and investment assets and attracting a valuation around US$20 billion in recent funding rounds.
That New Zealand corporate anchor is central to the claimants’ pitch that the High Court at Wellington is the proper forum, applying New Zealand company and tax law to a New Zealand‑registered company and its directors.
FNZ, however, has deployed an aggressive jurisdictional and procedural strategy aimed at staying or diverting the action.
Its legal team argues that the staff‑shareholders are bound by arbitration clauses and foreign governing‑law and jurisdiction provisions embedded in the company’s complex capital structure documentation, and that any substantive dispute must be determined by confidential arbitration – effectively shifting the battleground away from an open New Zealand court and towards London‑centric processes.
That clash is being heard first. In the opening day of the current two‑day hearing, FNZ’s lawyers told the High Court that arbitration was “inescapable,” urging the judge to halt the class action or at least carve out portions that must be determined by arbitrators rather than by a New Zealand judge in open court. For now, the jurisdiction and arbitration arguments are being conducted in chambers before a Wellington judge in line with High Court practice for such interlocutory applications.
FNZ’s defence and what’s next
FNZ, through external counsel and public statements, has vigorously denied the allegations, describing the claim as “entirely baseless” and characterising the employees’ narrative as “simplistic and inaccurate.”
The company maintains that the 2024–2025 capital raisings were “absolutely necessary and critical” to secure lifeline funding for FNZ’s global expansion and long‑term viability, arguing that the alternative – failing to raise capital on the terms available from sophisticated institutional investors – would have been catastrophic for all shareholders, including employees.
For New Zealand’s legal and corporate governance community, the case is shaping up as a potential watershed on how far boards can go in structuring complex, preference‑heavy capital raises that pit different shareholder classes against each other.
For the global fintech and private equity markets, the proceeding is being watched as an early test of how courts in a small, but sophisticated, jurisdiction will police conflicts of interest when powerful institutional investors and employee shareholders collide in late‑stage funding rounds.
The immediate question for the High Court is procedural: whether the multi‑billion‑dollar staff‑shareholder revolt will be allowed to proceed as an open class action in Wellington, or be fragmented and forced into arbitral forums and foreign courts.
If the employees succeed in keeping the case in the New Zealand courts, the subsequent discovery and substantive hearings will place unprecedented scrutiny on FNZ’s governance, its relationships with sovereign wealth and pension funds, and the playbook used to raise capital inside one of New Zealand’s most successful, and now most legally embattled, tech exports
